Device Devices

Gore Acuseal Cardiovascular Patch Vascular

Payments companies reported to CMS as associated with Gore Acuseal Cardiovascular Patch Vascular. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$7,873associated payments (2023-2025)
66clinicians with associated payments
1company reporting

By year

2023 $1,393
2024 $4,484
2025 $1,996

Payments reported as associated with Gore Acuseal Cardiovascular Patch Vascular, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Vascular Surgery $4,110
Surgery $892
Thoracic Surgery (Cardiothoracic Vascular Surgery) $647
Vascular & Interventional Radiology $603
Diagnostic Radiology $323
Family $256

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Gore Acuseal Cardiovascular Patch Vascular

These are the largest totals companies reported as associated with Gore Acuseal Cardiovascular Patch Vascular. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Bhavik Patel Waterloo, IA Thoracic Surgery (Cardiothoracic Vascular Surgery) $522.78
Kosisochi Obinwanne East Lansing, MI Surgery $375.06
Roger Moccia Orlando, FL Vascular Surgery $345.51
Irfan Imami Orlando, FL Vascular Surgery $328.86
Raymond Sutkowski Vero Beach, FL Diagnostic Radiology $323.09
David Tabriz Vero Beach, FL Vascular & Interventional Radiology $323.09
Edwin Cheung Deland, FL Vascular Surgery $322.42
Julio Calderin Kissimmee, FL Vascular Surgery $298.51
Jon Wesley Orlando, FL Vascular Surgery $230.92
Charles Thompson Orlando, FL Vascular Surgery $230.92

Prescribed Gore Acuseal Cardiovascular Patch Vascular?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.